Tradeweb Markets' Average Daily Volume Rises Over 20% in January-July 2024-www.financetom.com

Tradeweb Markets' Average Daily Volume Rises Over 20% in January

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tradeweb Markets' Average Daily Volume Rises Over 20% in January

Feb 6, 2025 6:46 AM

09:15 AM EST, 02/06/2025 (MT Newswires) -- Tradeweb Markets ( TW ) said Thursday that its average daily volume for January was $2.44 trillion, up 20.3% from a year earlier.

Total trading volume for the month was $54.6 trillion, the company said.

Tradeweb also said repurchase agreement average daily volume for January rose 33.8% year over year to $730.90 billion.

Previous page： Cbl & Associates Properties Insider Sold Shares Worth $370,501, According to a Recent SEC Filing Next page： Moderna, Merck to Begin Phase 2/3 Study of V940 Plus Pembrolizumab in Skin Cancer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cbl & Associates Properties Insider Sold Shares Worth $370,501, According to a Recent SEC Filing

Mar 11, 2024

02:22 PM EDT, 03/11/2024 (MT Newswires) -- Stephen D Lebovitz, Director, CEO, on March 07, 2024, sold 15,893 shares in Cbl & Associates Properties ( CBL ) for $370,501. Following the Form 4 filing with the SEC, Lebovitz has control over a total of 404,018 shares of the company, with 403,696 shares held directly and 322 controlled indirectly. SEC Filing:...

Moderna, Merck to Begin Phase 2/3 Study of V940 Plus Pembrolizumab in Skin Cancer

Mar 11, 2024

02:26 PM EDT, 03/11/2024 (MT Newswires) -- Moderna ( MRNA ) and Merck ( MRK ) will start a phase 2/3 study of cancer vaccine V940, or mRNA-4157, plus pembrolizumab in patients with cutaneous squamous cell carcinoma, a form of skin cancer, according to a government trial website. The study is expected to begin on April 18, according to ClinicalTrials.gov....

Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing

Mar 11, 2024

02:33 PM EDT, 03/11/2024 (MT Newswires) -- Kevin Guest, Executive Chairman of the Board, on March 11, 2024, sold 11,011 shares in Usana Health Sciences ( USNA ) for $539,539. Following the Form 4 filing with the SEC, Guest has control over a total of 10,491 shares of the company, with 10,491 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/896264/000089626424000115/xslF345X03/wk-form4_1710181559.xml Price: 49.12,...

Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing

Mar 11, 2024

02:32 PM EDT, 03/11/2024 (MT Newswires) -- Walter Noot, COO, on March 08, 2024, sold 5,240 shares in Usana Health Sciences ( USNA ) for $257,022. SEC Filing: https://www.sec.gov/Archives/edgar/data/896264/000089626424000113/xslF345X03/wk-form4_1710181361.xml Price: 49.05, Change: +0.47, Percent Change: +0.97 ...